The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae.
Farrell
David J
DJ
Felmingham
David
D
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006801:Humans; D048628:Ketolides / Q000494:pharmacology*; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000502:physiology; D013997:Time Factors
D000900:Anti-Bacterial Agents; D048628:Ketolides; C106791:telithromycin